CV Sciences, Inc.
CVSI
$0.0281
-$0.0079-21.94%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -5.48% | -0.30% | -3.52% | -1.76% | 9.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.48% | -0.30% | -3.52% | -1.76% | 9.01% |
| Cost of Revenue | -7.08% | -6.85% | -9.17% | -10.75% | 2.60% |
| Gross Profit | -3.53% | 8.27% | 3.98% | 11.52% | 17.99% |
| SG&A Expenses | -10.27% | -22.09% | 13.03% | -3.03% | -23.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.84% | -14.87% | 386.37% | -6.74% | -12.39% |
| Operating Income | 40.27% | 89.30% | -110.76% | 28.40% | 69.12% |
| Income Before Tax | -2.01% | 54.55% | -110.90% | 73.25% | 56.64% |
| Income Tax Expenses | -- | -- | -- | 81.63% | -- |
| Earnings from Continuing Operations | -2.01% | 54.66% | -111.01% | 73.12% | 56.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.01% | 54.66% | -111.01% | 73.12% | 56.64% |
| EBIT | 40.27% | 89.30% | -110.76% | 28.40% | 69.12% |
| EBITDA | 52.51% | 99.02% | -109.57% | 29.56% | 71.97% |
| EPS Basic | 13.79% | 59.52% | -110.40% | 73.83% | 58.57% |
| Normalized Basic EPS | 27.78% | 92.50% | -110.26% | 46.81% | 75.00% |
| EPS Diluted | 13.79% | 59.52% | -110.40% | 73.36% | 58.57% |
| Normalized Diluted EPS | 27.78% | 92.50% | -110.26% | 46.81% | 75.00% |
| Average Basic Shares Outstanding | 17.89% | 12.99% | 7.21% | 3.50% | 5.51% |
| Average Diluted Shares Outstanding | 17.89% | 12.99% | 7.21% | 3.50% | 5.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
